Clinical Trial Update: A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

Pilot phase 1/2 trial evaluating N-acetylcysteine in patients with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Bloodworks | Conditions: Sickle Cell Disease, Sickle Cell Anemia | Phase 1, Phase 2 | Status: COMPLETED